Restricted Eating Time in the Treatment of Type 2 Diabetes - the RESET2 Trial.
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The overall aim of the present study is to investigate the effectiveness of implementing a 1-year time-restricted eating (TRE)-based intervention on glycaemic control, body weight and composition, cardiometabolic risk factors, and behaviour in individuals with overweight/obesity and type 2 diabetes (T2D).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age: ≥18 years
• Overweight or obesity (BMI ≥25 kg/m2)
• T2D with HbA1c\>53 mmol/mol
• Habitual eating window ≥12 h/day (incl. foods/snacks and energy-containing beverages)
Locations
Other Locations
Denmark
Steno Diabetes Center Copenhagen
RECRUITING
Herlev
Contact Information
Primary
Jonas S Quist, PhD
jonas.salling.quist@regionh.dk
+45 26176064
Time Frame
Start Date: 2024-03-21
Estimated Completion Date: 2026-05-01
Participants
Target number of participants: 160
Treatments
Experimental: Time-restricted eating
TRE group for 1 year: The intervention consists of a 3-month (12 weeks) strict TRE period, where participants follow the same eating window each day with minimal support, followed by a 9-month (40 weeks) period of individually adjusted TRE according to their experiences.
No_intervention: Control
Control group for 1 year: Participants will be instructed to continue their habitual lifestyle during the study and they will follow standard care with regular visits at the SDCC clinic 3-4 times/year.
Related Therapeutic Areas
Sponsors
Collaborators: Salk Institute for Biological Studies, University of Copenhagen, University of Leeds, Glostrup University Hospital, Copenhagen
Leads: Steno Diabetes Center Copenhagen